Related references
Note: Only part of the references are listed.Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma
Deborah R. Caswell et al.
MOLECULAR CANCER RESEARCH (2018)
Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics
Shao Thing Teoh et al.
FRONTIERS IN ONCOLOGY (2018)
Comprehensive gene copy number alterations profiling predict efficacy of adjuvant chemotherapy in resected stage II-IIIA lung adenocarcinoma.
Qiaoyun Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genome-Wide Copy Number Alterations Profiling Predict Efficacy of Resected Stage II-IIIA Lung Adenocarcinoma
X. Han et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
M. Choi et al.
ANNALS OF ONCOLOGY (2017)
Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer
Zhe-Wei Qiu et al.
GENES CHROMOSOMES & CANCER (2017)
ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies
Jody C. Chuang et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
Eun Kyung Kim et al.
PLOS ONE (2017)
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy
Siraj M. Ali et al.
CANCER (2017)
Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancerA survey across 822 routine diagnostic cases
Nicole Pfarr et al.
GENES CHROMOSOMES & CANCER (2016)
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling
Joseph M. Foster et al.
BMC MEDICAL GENOMICS (2015)
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
Mark L. McCleland et al.
CLINICAL CANCER RESEARCH (2013)
Genomic amplification and drug-resistance roles of the KDM5A histone demethylase gene in breast cancer
Jinling Hou et al.
CANCER RESEARCH (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
Nick Craddock et al.
NATURE (2010)
Allele-specific copy number analysis of tumors
Peter Van Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
c-Myc: Linking transformation and genomic instability
Edward V. Prochownik
CURRENT MOLECULAR MEDICINE (2008)
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer
K. A. Kwei et al.
ONCOGENE (2008)
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
Jacques Lapointe et al.
CANCER RESEARCH (2007)
RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3
Jesper Christensen et al.
CELL (2007)
The retinoblastoma binding protein RBP2 is an H3K4 demethylase
Robert J. Klose et al.
CELL (2007)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer
Yue Chen et al.
LUNG CANCER (2006)
Global gene expression profiling of pleural mesotheliomas:: Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
F López-Ríos et al.
CANCER RESEARCH (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer
MD Bashyam et al.
NEOPLASIA (2005)
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines
S Raschke et al.
GENES CHROMOSOMES & CANCER (2005)
Metagenes and molecular pattern discovery using matrix factorization
JP Brunet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1
S Rodriguez et al.
ONCOGENE (2003)
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions
PB Illei et al.
CANCER CYTOPATHOLOGY (2003)
Share Paper
